IMUX

Conviction 86HealthcareScan · Mon, Aug 10, 2026

IMUX$14.09-1.50%

ResistanceSupportVol 14

Vol MA14 183.45K

May 11May 28Jun 16Jul 6Jul 23Aug 10

IMMUNIC, INC.PHARMACEUTICAL PREPARATIONSwww.imux.com ↗

Price14.09

Change-1.50%

Gap-0.07%

Rel volume2.70×

Avg volume173.23K

Avg $ vol2.48M

SMA 2014.31

SMA 5014.32

SMA 2005.46

Price vs 50-1.61%

Price vs 200+157.86%

MA stackmixed

50/200 cross—

Supertrendup · 12.56

RSI (14)49

MACD hist-0.02

MACD cross—

Stoch %K / %D47 / 53

ADX (14)20

+DI / −DI20 / 14

RSI divergence—

MACD divergence—

ATR %+6.53%

ADR %6.40%

52w high15.41

52w low0.5102

From 52w high-8.60%

Above 52w low+2660.68%

New 52w highNo

SqueezeOn · 2d

Bollinger width17.66%

%B0.41

Donchian pos43.63%

Donchian high15.84

Donchian low12.73

AVWAP (52w high)14.62

vs AVWAP high-3.65%

AVWAP (52w low)1.69

vs AVWAP low+732.98%

OBV trendDown

Chaikin MF (20)-0.12

Today vs 20d2.70×

Avg vol (14d)183.45K

Avg vol (20d)173.23K

Avg $ vol (20d)2.48M

Market cap191.86M

RS 3m (vs SPY)+16.00%

RS 6m (vs SPY)+2313.73%

RS line new highNo

Trend template7/8

Technical rank71.7

1 week-0.11%

1 month-4.64%

3 months+21.11%

6 months+2171.77%

1 year+1461.01%

YTD+2315.95%

P/E-1.97

P/B1.27

P/S—

P/FCF-2.23

EPS-0.6200

Div yield—

ROE-64.25%

ROA-51.21%

Debt/Eq—

Current4.92

EV/EBITDA-0.05

Gross margin—

Net margin—

Rev growth—

EPS growth3.32%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value5.23M

Revenue22K

Net income-32.59M

Gross profit9K

Free cash flow-85.97M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees95

ListedThu, Apr 17, 2014

Free float120.71M

Float %88.6%

Short interest1.41M

Days to cover9.5d

Short volume65.5%

Squeeze score59 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction86 / 100

Pattern quality—

Tech rank71.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance15.79

Support13.43

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMUX

All disclosures →

No recent disclosed trades by Congress in IMUX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMUX · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Congleton Jon Director · Stock Option · 2026-07-05	Grant	25.37K	—	2026-07-05	2026-07-07
Rudick Richard Alan Director · Stock Option · 2026-07-05	Grant	25.37K	—	2026-07-05	2026-07-07
Neermann Joerg Director · Stock Option · 2026-07-05	Grant	25.37K	—	2026-07-05	2026-07-07
Skerjanec Simona Director · Stock Option · 2026-07-05	Grant	25.37K	—	2026-07-05	2026-07-07
PHILLIPS BARCLAY A Director · Stock Option · 2026-07-05	Grant	25.37K	—	2026-07-05	2026-07-07
Congleton Jon Director · Stock Option · 2026-06-29	Grant	50.74K	—	2026-06-29	2026-06-29
HOWSON TAMAR D Director · Stock Option · 2026-06-29	Grant	25.37K	—	2026-06-29	2026-06-29
BONNEY MICHAEL W Director · Stock Option · 2026-06-29	Grant	100K	—	2026-06-29	2026-06-29
Vitt Daniel Director · Stock Option · 2026-06-29	Grant	445K	—	2026-06-29	2026-06-29
Whaley Glenn Chief Financial Officer · Stock Option · 2026-06-29	Grant	120K	—	2026-06-29	2026-06-29

SEC filings

EDGAR filings in IMUX · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.